From add‑on to infrastructure: integrating AI and machine learning tools in vaccine development

“AI helps us explore design spaces that humans cannot even enumerate, whether we are working with protein or nucleic acid sequences.”

Charlotte Barker, Commissioning Editor, Vaccine Insights, speaks with Magda Zwierzyna, Scientific Director, Head CMC AI/ML Delivery, GSK, about where AI and machine learning are adding the most value in vaccine development, successful collaboration between computational and experimental scientists, and why the roadblocks are rarely technical.

Please enter your email to access content Read now